I-Metaiodobenzylguanidine Myocardial Scintigraphy in Lewy Body-Related Disorders: A Literature Review

• Main Authors: Eun Joo Chung, Sang Jin Kim
• Format: Article
• Language: English
• Published: Korean Movement Disorders Society 2015-05-01
• Series: Journal of Movement Disorders
• Subjects: I-metaiodobenzylguanidine scintigraphy; Lewy body-related disorders; Parkinsonism; Dementia
• Online Access: http://e-jmd.org/upload/jmd-8-2-55.pdf

Lewy body-related disorders are characterized by the presence of Lewy bodies and Lewy neurites, which have abnormal aggregations of α-synuclein in the nigral and extranigral areas, including in the heart. 123I-metaiodobenzylguanidine (MIBG) scintigraphy is a well-known tool to evaluate cardiac sympathetic denervation in the Lewy body-related disorders. MIBG scintigraphy showed low uptake of MIBG in the Lewy body-related disorders, including Parkinson’s disease, dementia with Lewy bodies, pure autonomic failure and rapid eye movement sleep behavior disorder. This review summarizes previous results on the diagnostic applications of MIBG scintigraphy in Lewy body-related disorders.